Profile data is unavailable for this security.
About the company
PT Pyridam Farma Tbk is an Indonesia-based pharmaceutical company. The Company is engaged in the production, development, and trade of pharmaceuticals, as well as the trade of medical devices and cosmetics. Its segments include pharmaceutical products, esthetic, and toll manufacturing services; and medical equipments. It offers products across consumer health, pyfaesthetic, sanitizer and antiseptic, sterile/injection, biomedilab, betadine group and guardix, and medical support categories. The consumer health category provides over the counter drugs, including supplements and other preventive products, along with energy drinks and healthy ready-to-drink products. Its pyfaesthetic category includes products, such as Arosa Gel, A-Stark Gel, Hymen Gel, Pyderen Emulsion, Tonic Bust Emulsion, Calmosan Cream, and Di-Herb Gel. Its sterile/injection category is focused on injection products. Its biomedilab category provides various medical equipment and tools for hospital laboratories.
- Revenue in IDR (TTM)795.77bn
- Net income in IDR-142.37bn
- Incorporated1977
- Employees1.33k
- LocationPyridam Farma Tbk PTJalan Kemandoran 8 No 16JAKARTA 12920IndonesiaIDN
- Phone+62 2 153690112
- Fax+62 215329049
- Websitehttps://www.pyfa.co.id/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lifecore Biomedical Inc | 2.00tn | 88.98bn | 2.66tn | 524.00 | 125.61 | -- | 11.87 | 1.33 | 0.0369 | 0.0595 | 3.82 | 1.28 | 0.5217 | 2.01 | 4.96 | 245,124.00 | 2.32 | -5.91 | 2.74 | -8.33 | 34.65 | 31.01 | 4.45 | -19.16 | 0.803 | 0.125 | 0.7641 | -- | 24.20 | -25.46 | 114.53 | 34.47 | -16.72 | -- |
Kopran Ltd | 1.18tn | 109.88bn | 2.66tn | 358.00 | 20.52 | -- | 19.74 | 2.26 | 14.53 | 14.53 | 150.01 | -- | -- | -- | -- | 17,794,040.00 | -- | 8.47 | -- | 12.23 | 36.03 | 32.93 | 9.31 | 8.89 | -- | 27.17 | -- | 25.41 | 11.54 | 11.42 | 87.11 | 16.23 | 12.53 | -- |
Sinphar Pharmaceutical Co Ltd | 1.46tn | 174.64bn | 2.72tn | 984.00 | 14.44 | 1.67 | 9.55 | 1.87 | 2.15 | 2.15 | 17.93 | 18.61 | 0.4864 | 2.28 | 6.06 | -- | 5.71 | -0.0147 | 7.67 | -0.0203 | 39.02 | 37.49 | 11.74 | -0.0344 | 1.44 | 37.22 | 0.3599 | 79.70 | 3.72 | 5.98 | 67.01 | 111.88 | 3.31 | 58.49 |
Cenra Inc | 4.29tn | 171.68bn | 2.80tn | 1.40k | 32.58 | 1.56 | 8.25 | 0.6518 | 1.19 | 1.19 | 29.73 | 24.90 | 0.7027 | 2.22 | 5.63 | -- | 2.83 | 3.69 | 4.03 | 4.96 | 36.79 | 36.56 | 4.02 | 5.50 | 0.7959 | -- | 0.2943 | 52.77 | 1.40 | 2.50 | -32.51 | -2.72 | 3.57 | -8.97 |
Newron Pharmaceuticals SpA | 118.21bn | -319.37bn | 2.80tn | 23.00 | -- | -- | -- | 23.66 | -0.9707 | -0.9707 | 0.3593 | -1.52 | 0.247 | -- | 3.46 | 284,341.50 | -66.74 | -37.10 | -109.83 | -43.98 | 93.37 | 91.72 | -270.17 | -270.48 | -- | -3.53 | 2.71 | -- | 48.62 | 17.61 | 7.25 | -- | -22.76 | -- |
Shaanxi Kanghui Pharmaceutical Co Ltd | 1.46tn | -103.86bn | 2.83tn | 952.00 | -- | 1.38 | -- | 1.94 | -0.4752 | -0.4752 | 6.70 | 9.42 | 0.3167 | 1.94 | 3.35 | 703,079.60 | -3.63 | -0.1562 | -5.54 | -0.1991 | 26.27 | 40.00 | -11.48 | -0.4907 | 0.8792 | -0.7684 | 0.4201 | 95.15 | 36.92 | 12.37 | 58.52 | -- | 66.95 | -- |
Mediwound Ltd | 313.80bn | -311.18bn | 2.87tn | 100.00 | -- | 8.88 | -- | 9.15 | -2.16 | -2.16 | 2.18 | 1.92 | 0.3311 | 5.53 | 6.55 | 201,410.00 | -32.83 | -24.48 | -49.28 | -32.92 | 13.25 | 43.27 | -99.17 | -38.43 | 1.51 | -3.26 | 0.2623 | -- | -29.48 | 40.60 | 65.73 | -- | 64.66 | -- |
Pyridam Farma Tbk PT | 795.77bn | -142.37bn | 2.92tn | 1.33k | -- | 2.16 | -- | 3.67 | -41.98 | -41.98 | 170.10 | 120.12 | 0.2073 | 1.37 | 2.16 | 667,036,500.00 | -3.99 | 6.31 | -6.16 | 8.07 | 38.35 | 42.56 | -19.23 | 8.83 | 0.5474 | -0.5882 | 0.7473 | -- | -1.87 | 22.89 | -130.96 | -- | 2.93 | -- |